Methods of preparing compounds useful as protease inhibitors

Details for Australian Patent Application No. 2004295186 (hide)

Owner Pfizer Inc.

Inventors Saeed, Nabil Lauze; Kucera, David John; Scott, Robert William

Agent Spruson & Ferguson

Pub. Number AU-A-2004295186

PCT Pub. Number WO2005/054187

Priority 60/527,470 04.12.03 US; 60/591,354 26.07.04 US

Filing date 22 November 2004

Wipo publication date 16 June 2005

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054187 Priority application(s): WO2005/054187

20 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295187-Methods for the preparation of stereoisomerically enriched amines

2004295178-Therapeutics use of pyridinium compounds to modulate NAADP activity